4th AMLD Directive Just took effect, page-5

First 5 Last

Share
Profile

Follow
Transplant

479 Posts.

32

27/06/17

23:49

Post #: 25527207
Share

Originally posted by michaelhp ↑

yep, John has now shot an arrow across their bow. The gauntlet has been laid down and this is going to get interesting. The ISX engineers are going to need some vitamin B and extra vitamins to compensate for the lack of sleep over the next 6 months. Many who sign up now will still be in the queue for 'go live status' 6 months from now. The 1st to be fined will be like a poison arrow hitting the a of the laziest, fattest of the herd- the rest of the herd will leap forward and attempt to stay alive - and the discounting that was on offer for 'early movers' will no longer exist. Pay up and comply or cease operations.

JK and this co it seems are in a very enviable position, and it seems to just get better by the day. I must admit my position is quite sizeable by my standards and I had intended to offload some at 16c. I pulled those offers late last week and am putting my 'trader' hat away for this stock and seeking serious capital appreciation in the next 6 months. IMHO I see no way this company does not get a serious buyout proposal in the next 6 months!

I do this for a living and don't invest with emotion, but I must admit - this looks good!!!!!

Regulations are not going away. AML is just the start. We also have MiFID coming into effect early 2018. Compliance and KYC related issues are becoming the elephant in the room. ISX is the mouse that is about to upend this industry.

All IMHO.

Expand

Yep, too good to trade now.
Release the bulls.
Agree there will be big players wanting to own the ISX future.

ISX Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

OPL

Opyl forms JV with UK and US consortium to bring products to the world

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement